Indication
EGFR Gene Mutation
1 clinical trial
5 products
Clinical trial
A Phase 1/1b Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Lung CancerStatus: Active (not recruiting), Estimated PCD: 2024-08-01
Product
ZimberelimabProduct
CarboplatinProduct
PemetrexedProduct
PembrolizumabProduct
Etrumadenant